Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases

American Journal of Clinical Pathology
C D WuL J Medeiros

Abstract

Splenic marginal zone cell lymphoma (SMZCL) is a recently described clinicopathologic entity, that is reported to overlap with splenic B-cell lymphoma with villous lymphocytes. The authors describe the clinicopathologic, immunophenotypic, and molecular findings in five cases of SMZCL. There were two males and three females, with a mean age of 68.4 years, who presented with peripheral blood cytopenias and splenomegaly. One patient had an absolute lymphocytosis with many villous lymphocytes. With clinical follow-up of 9 to 37 months, two patients are alive and three patients died of unrelated causes. Splenectomy was done in each patient and the spleens were large, 970-2,400 g. Histologically, the SMZCLs preferentially replaced the marginal and mantle zones with partial or complete replacement of germinal centers in the white pump. The neoplastic cells were predominantly small to medium in size with oval or slightly irregular nuclei and relatively abundant pale or eosinophilic cytoplasm. Immunophenotypic studies demonstrated that the neoplastic cells expressed monotypic immunoglobulin, IgD in four tumors, pan-B-cell antigens, and bcl-2. The tumor cells were negative for the CD2, CD3, CD5, CD10, CD11c, CD25, CD35, CD38, CD45RO, and...Continue Reading

Citations

Nov 26, 1997·American Journal of Hematology·H MurakamiM Kojima
Jun 22, 2000·Genes, Chromosomes & Cancer·M M OttH K Müller-Hermelink
Dec 16, 2000·The American Journal of Surgical Pathology·J P Duong Van HuyenJ Diebold
Feb 28, 2007·The American Journal of Surgical Pathology·Theodora PapadakiDimitra Anagnostou
Jan 15, 1999·The American Journal of Surgical Pathology·E CampoE S Jaffe
Nov 2, 2001·The American Journal of Surgical Pathology·F I CamachoM A Piris
Nov 26, 2002·Blood·Vito FrancoEmilio Iannitto

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.